Migraine is a common disorder in childhood and adolescence. Studies on adults show the effectiveness and tolerability of riboflavin in migraine prevention, while data on children are scarce. This retrospective study reports on our experience of using riboflavin for migraine prophylaxis in 41 pediatric and adolescent patients, who received 200 or 400 mg/day single oral dose of riboflavin for 3, 4 or 6 months. Attack frequency and intensity decreased (P < 0.01) during treatment, and these results were confirmed during the follow-up. A large number of patients (77.1%) reported that abortive drugs were effective for controlling ictal events. During the follow-up, 68.4% of cases had a 50% or greater reduction in frequency of attacks and 21.0% in intensity. Two patients had vomiting and increased appetite, respectively, most likely for causes unrelated to the use of riboflavin. In conclusion, riboflavin seems to be a well-tolerated, effective, and low-cost prophylactic treatment in children and adolescents suffering from migraine.

M. Condò, A. Posar, A. Arbizzani, A. Parmeggiani (2009). Riboflavin prophylaxis in pediatric and adolescent migraine. THE JOURNAL OF HEADACHE AND PAIN, 10, 361-365 [10.1007/s10194-009-0142-2].

Riboflavin prophylaxis in pediatric and adolescent migraine

POSAR, ANNIO;PARMEGGIANI, ANTONIA
2009

Abstract

Migraine is a common disorder in childhood and adolescence. Studies on adults show the effectiveness and tolerability of riboflavin in migraine prevention, while data on children are scarce. This retrospective study reports on our experience of using riboflavin for migraine prophylaxis in 41 pediatric and adolescent patients, who received 200 or 400 mg/day single oral dose of riboflavin for 3, 4 or 6 months. Attack frequency and intensity decreased (P < 0.01) during treatment, and these results were confirmed during the follow-up. A large number of patients (77.1%) reported that abortive drugs were effective for controlling ictal events. During the follow-up, 68.4% of cases had a 50% or greater reduction in frequency of attacks and 21.0% in intensity. Two patients had vomiting and increased appetite, respectively, most likely for causes unrelated to the use of riboflavin. In conclusion, riboflavin seems to be a well-tolerated, effective, and low-cost prophylactic treatment in children and adolescents suffering from migraine.
2009
M. Condò, A. Posar, A. Arbizzani, A. Parmeggiani (2009). Riboflavin prophylaxis in pediatric and adolescent migraine. THE JOURNAL OF HEADACHE AND PAIN, 10, 361-365 [10.1007/s10194-009-0142-2].
M. Condò; A. Posar; A. Arbizzani; A. Parmeggiani
File in questo prodotto:
File Dimensione Formato  
Riboflavin prophylaxis in pediatric and adolescent migraine.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 349.34 kB
Formato Adobe PDF
349.34 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/76907
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 104
  • ???jsp.display-item.citation.isi??? 77
social impact